Cargando…
A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy
BACKGROUND: Antigen-specific cytotoxic T lymphocytes (CTLs), which eliminate target cells bearing antigenic peptides presented by surface major histocompatibility complex (MHC) class I molecules, play a key role in cancer immunotherapy. However, the majority of tumors are not immunologically rejecte...
Autores principales: | Shin, Jung Min, Song, Seok Ho, Vijayakameswara Rao, N., Lee, Eun Sook, Ko, Hyewon, Park, Jae Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092827/ https://www.ncbi.nlm.nih.gov/pubmed/30128166 http://dx.doi.org/10.1186/s40824-018-0131-0 |
Ejemplares similares
-
Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy
por: Rao, N. Vijayakameswara, et al.
Publicado: (2018) -
Water-Dispersible
Carboxymethyl Dextran-Coated Melamine
Nanoparticles for Biosensing Applications
por: Kurihara, Yoshikazu, et al.
Publicado: (2022) -
Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery
por: Cordeiro, Ana Sara, et al.
Publicado: (2021) -
Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma
por: Dalvin, Lauren A
Publicado: (2022) -
Characterization of Serine Protease Inhibitor from Solanum tuberosum Conjugated to Soluble Dextran and
Particle Carriers
por: Billinger, Erika, et al.
Publicado: (2019)